Journals / Anatolian Current Medical Journal / 2021 / Cilt: 3 - Sayı: 4

Blood gas analysis syringes containing spray-dosed droplet liquid heparin may decrease sample rejection ratios

Pages
284–290
Publication Date
2021-09-24
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: Mean SRRs of the groups by percentage (%) were calculated as 6.1±1.5, 10.0±0.9, and 3.8±0.9, respectively, and showed a statistically significant difference (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: The objective of this study is to evaluate blood gas analysis (BGA) sample rejection ratios (SRRs) in our laboratory and investigate the effect of various BGA syringes on SRR.
📊
Key Findings & Data:Material and Method: 3 groups were formed based on the type and use period of BGA syringes.
💡
Conclusion & Impact:Results: Mean SRRs of the groups by percentage (%) were calculated as 6.1±1.5, 10.0±0.9, and 3.8±0.9, respectively, and showed a statistically significant difference (p
🔬Design:Research Article
📍Scope:2018 Verileri
⚙️Variables:Blood gas analysis · sample rejection ratio · preanalytical phase

Abstract

Aim: The objective of this study is to evaluate blood gas analysis (BGA) sample rejection ratios (SRRs) in our laboratory and investigate the effect of various BGA syringes on SRR. Material and Method: 3 groups were formed based on the type and use period of BGA syringes. Syringes containing spray-dosed droplet liquid Lithium Heparin were used in Group 1 (November 2018–May 2019), syringes containing lyophilized dried Lithium Heparin were used in Group 2 (July 2019–January 2020), and another syringes containing spray-dosed droplet liquid Lithium Heparin were used in Group 3 (March 2020–September 2020), and the groups were determined based on such use. SRRs of these groups were calculated, causes for sample rejection were identified, and department-based investigations were conducted. Comparisons between groups were performed according to the indicated variables. Results: Mean SRRs of the groups by percentage (%) were calculated as 6.1±1.5, 10.0±0.9, and 3.8±0.9, respectively, and showed a statistically significant difference (p

🔖

Cite This Article

UÇAR, K. T., NURLU, N. (2021). Blood gas analysis syringes containing spray-dosed droplet liquid heparin may decrease sample rejection ratios. Anatolian Current Medical Journal, Cilt: 3 - Sayı: 4, 284–290. https://ajindex.com/articles/733805

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Lippi G, Baird GS, Banfi G, et al. Improving quality in the preanalytical phase through innovation, on behalf of the European Federation for Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for Preanalytical Phase (WG-PRE). Clin Chem Lab Med 2017; 55: 489–500.
  2. Lippi G, Panteghini M, Bernardini S, et al. Laboratory testing in the emergency department: An Italian Society of Clinical Biochemistry and Clinical Molecular Biology (SIBioC) and Academy of Emergency Medicine and Care (AcEMC) consensus report. Clin Chem Lab Med 2018; 56: 1655–9.
  3. Davis MD, Walsh BK, Sittig SE, Restrepo RD. AARC clinical practice guideline: blood gas analysis and hemoximetry: 2013. Respir Care 2013; 58: 1694–703. Baird G. Preanalytical considerations in blood gas analysis. Biochem Medica 2013; 23: 19–27. Shaw JLV. Practical challenges related to point of care testing. Pract Lab Med 2016; 4: 22–9.
  4. Quig K, Wheatley EG, O’Hara M. Perspectives on blood-based point-of-care diagnostics. Open Access Emerg Med 2019; 11: 291–6.
  5. Aykal G, Keşapli M, Aydin Ö, et al. Pre-test and post-test applications to shape the education of phlebotomists in a quality management program: An experience in a training hospital. J Med Biochem 2016; 35: 347–53.
  6. Gunnur Dikmen Z, Pinar A, Akbiyik F. Specimen rejection in laboratory medicine: Necessary for patient safety? Biochem Medica 2015; 25: 377–85. CLSI. Procedures for the collection of diagnostic blood specimens by Venipuncture; approved standard—sixth edition. CLSI document GP41-A6. Wayne, PA: Clinical and Laboratory Standards Institute; 2007.
  7. Oliver P, Fernandez-Calle P, Mora R, et al. Real-world use of key performance indicators for point-of-care testing network accredited by ISO 22870. Pract Lab Med 2020; 22. Lippi G, Betsou F, Cadamuro J, et al. Preanalytical challenges-time for solutions. Clin Chem Lab Med 2019; 57: 974–81. Dukić L, Kopčinović LM, Dorotić A, Baršić I. Blood gas testing and related measurements: National recommendations on behalf of the Croatian society of medical biochemistry and laboratory medicine. Biochem Medica 2016; 26: 318–36.
  8. Peck Palmer OM, Wheeler SE, Plebani M, Patterson PD, Korpi-Steiner NL, Martin C. Recognition of the prehospital preanalytical phase: collaborative efforts between laboratory medicine and emergency medicine to ensure quality testing. Clin Chem 2020; 66: 998–1005.
  9. Cantero M, Redondo M, Martín E, Callejón G, Hortas ML. Use of quality indicators to compare point-of-care testing errors in a neonatal u